0001209191-15-077834.txt : 20151102 0001209191-15-077834.hdr.sgml : 20151102 20151102170801 ACCESSION NUMBER: 0001209191-15-077834 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151102 FILED AS OF DATE: 20151102 DATE AS OF CHANGE: 20151102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Steris plc CENTRAL INDEX KEY: 0001624899 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 981203539 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1031 BUSINESS ADDRESS: STREET 1: CHANCERY HOUSE, 190 WATERSIDE ROAD STREET 2: HAMILTON INDUSTRIAL PARK CITY: LEICESTER STATE: X0 ZIP: LE5 1QZ BUSINESS PHONE: (440) 354-2600 MAIL ADDRESS: STREET 1: CHANCERY HOUSE, 190 WATERSIDE ROAD STREET 2: HAMILTON INDUSTRIAL PARK CITY: LEICESTER STATE: X0 ZIP: LE5 1QZ FORMER COMPANY: FORMER CONFORMED NAME: New STERIS Ltd DATE OF NAME CHANGE: 20141125 FORMER COMPANY: FORMER CONFORMED NAME: Solar New HoldCo Ltd DATE OF NAME CHANGE: 20141112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Khan Gulam Amjad CENTRAL INDEX KEY: 0001651656 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37614 FILM NUMBER: 151191379 MAIL ADDRESS: STREET 1: 5960 HEISLEY ROAD CITY: MENTOR STATE: OH ZIP: 44060 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-11-02 0 0001624899 Steris plc STE 0001651656 Khan Gulam Amjad C/O CHANCERY HOUSE, 190 WATERSIDE ROAD HAMILTON INDUSTRIAL PARK LEICESTER X0 LE5 1QZ UNITED KINGDOM 0 1 0 0 Sr. V.P., Procedural Solutions Ordinary Shares, ?0.10 Nominal Value 2015-11-02 4 A 0 7000 A 7000 D Employee Stock Option (right to buy) 65.05 2015-11-02 4 A 0 11700 A 2025-08-27 Ordinary Shares, ?0.10 Nominal Value 11700 11700 D All 7,000 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019. Represents ordinary shares of STERIS plc ("New STERIS") acquired pursuant to merger of a wholly-owned subsidiary of New STERIS with and into STERIS Corporation ("STERIS"), with STERIS surviving the merger as a wholly-owned subsidiary of New STERIS (the "Merger"), in exchange for common shares of STERIS, which was consummated simultaneous with and conditioned on New STERIS' acquisition of Synergy Health plc by commencing a "recommended offer" under English law. At the effective time of the Merger, each STERIS common share was cancelled and converted into the right to receive one New STERIS ordinary share. This option becomes exercisable as follows: 2,925 on May 28, 2016; 2,925 on May 28, 2017; 2,925 on May 28, 2018 and 2,925 on May 28, 2019. This option was received in the Merger in exchange for an option to purchase 11,700 STERIS common shares for $65.05 per share, subject to the same terms and conditions as the original STERIS stock option. /s/ Dennis P. Patton, Authorized Representative under Power of Attorney 2015-11-02